rs281864819
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_000517.6(HBA2):c.70G>A(p.Glu24Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E24G) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 2)
Exomes 𝑓: 0.0000048 ( 1 hom. )
Failed GnomAD Quality Control
Consequence
HBA2
NM_000517.6 missense
NM_000517.6 missense
Scores
3
6
6
Clinical Significance
Conservation
PhyloP100: 2.32
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBA2 | NM_000517.6 | c.70G>A | p.Glu24Lys | missense_variant | 1/3 | ENST00000251595.11 | NP_000508.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA2 | ENST00000251595.11 | c.70G>A | p.Glu24Lys | missense_variant | 1/3 | 1 | NM_000517.6 | ENSP00000251595 | P1 | |
HBA2 | ENST00000484216.1 | c.40G>A | p.Glu14Lys | missense_variant | 1/2 | 1 | ENSP00000495899 | |||
HBA2 | ENST00000482565.1 | n.89G>A | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
HBA2 | ENST00000397806.1 | c.-2+24G>A | intron_variant | 2 | ENSP00000380908 |
Frequencies
GnomAD3 genomes Cov.: 2
GnomAD3 genomes
Cov.:
2
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000476 AC: 2AN: 420018Hom.: 1 Cov.: 0 AF XY: 0.00000906 AC XY: 2AN XY: 220816
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
2
AN:
420018
Hom.:
Cov.:
0
AF XY:
AC XY:
2
AN XY:
220816
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 2
GnomAD4 genome
Cov.:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 05, 2023 | The Hb Chad variant (HBA2: c.70G>A; p.Glu24Lys, also known as Glu23Lys when numbered from the mature protein, rs281864819) is reported in the literature in individuals with hypochromia or no clinical symptoms, and does not contribute to the clinical phenotype when found with other structural variants (see link to HbVar database for Hb Chad and references therein). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.535). Additionally, other variants at this codon (Hb Memphis, Hb G-Audhali, Hb Dayton, Hb Reims, Hb Lisbon) have been reported in individuals with no clinical symptoms (see link to HbVar database and references therein). While the available information suggests that this is a benign structural variant, due to the presence of individuals with hypochromia, the clinical significance of the Hb Chad variant is uncertain at this time. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html - |
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | May 31, 2023 | In the published literature, this variant has been reported in individuals and families examined for hemoglobin variation in Chad (PMID: 5714528 (1968)), China (PMID: 4786652 (1973)), Japan (PMID: 6689417 (1983)), and Suriname (PMID: 2606723 (1989)). Some individuals heterozygous for this variant have normal clinical presentations while others presented with microcytosis and hypochromia (PMID: 2606723 (1989)), as well as polycythemia (PMID: 6689417 (1983)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is deleterious or benign. Based on the available information, we are unable to determine the clinical significance of this variant. - |
alpha Thalassemia Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | May 21, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Benign
T
Vest4
MutPred
Gain of MoRF binding (P = 0.0073);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at